114 related articles for article (PubMed ID: 142260)
1. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
Deutsch M; Ananth JV; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
[No Abstract] [Full Text] [Related]
2. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
[No Abstract] [Full Text] [Related]
3. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
Wittkopp TA; Abuzzahab FS
Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
[No Abstract] [Full Text] [Related]
4. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
Hoffer A
Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426
[No Abstract] [Full Text] [Related]
5. Nicotinic acid in the treatment of schizophrenia.
Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
[No Abstract] [Full Text] [Related]
6. A placebo-controlled clinical study with trazodone in schizophrenic patients.
Lehmann HE; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):11-2. PubMed ID: 329320
[No Abstract] [Full Text] [Related]
7. A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
Amin MM; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):20-1. PubMed ID: 329325
[No Abstract] [Full Text] [Related]
8. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia.
Vallely JF; Lovegrove TD; Hobbs GE
Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335
[No Abstract] [Full Text] [Related]
9. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.
Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J
Can Med Assoc J; 1970 May; 102(9):939-42. PubMed ID: 4157149
[TBL] [Abstract][Full Text] [Related]
10. Piperidine in chronic schizophrenic patients: a controlled double-blind study.
Luchins DJ; Gillin JC; Wagner RL; DeLisi LE; Morihisa JM; Weinberger DR; Bigelow LB; Klein ST; Wyatt RJ
Biol Psychiatry; 1981 Jan; 16(1):91-5. PubMed ID: 6112021
[No Abstract] [Full Text] [Related]
11. A double-blind, placebo-controlled study of Ru-Vert in patients with vertigo.
Pou JW; Quinn HJ
Curr Ther Res Clin Exp; 1967 Nov; 9(11):558-62. PubMed ID: 4965504
[No Abstract] [Full Text] [Related]
12. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
Saarma J; Vasar H
Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126
[No Abstract] [Full Text] [Related]
13. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
15. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
Amin MM; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
[No Abstract] [Full Text] [Related]
16. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
17. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
Clark ML; Paredes A; Costiloe JP; Wood F
Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
[TBL] [Abstract][Full Text] [Related]
18. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
Vergara L; Amin MM; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
[No Abstract] [Full Text] [Related]
19. [Active therapeutic exercises in combination with vasoactive drug in intermittent claudication (author's transl)].
Krause D; Dittmar K
MMW Munch Med Wochenschr; 1978 Jan; 120(2-3):69-72. PubMed ID: 414129
[TBL] [Abstract][Full Text] [Related]
20. A standard-controlled clinical study with propericiazine in schizophrenic patients.
Ananth JV; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
